|
Real-time Estimate
Cboe BZX
11:07:17 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 58.83 USD | -0.89% |
|
+1.38% | -8.55% |
| 09-24 | Dolby Laboratories, Meta Expand Dolby Features Across Devices, Instagram | MT |
| 09-23 | Dolby Laboratories, Inc. and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem | CI |
Company Valuation: Dolby Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 9,375 | 6,589 | 7,494 | 7,231 | 6,938 | 5,560 | - | - |
| Change | - | -29.72% | 13.74% | -3.51% | -4.05% | -19.86% | - | - |
| Enterprise Value (EV) | 8,103 | 5,772 | 7,494 | 7,231 | 6,938 | 5,560 | 5,560 | 5,560 |
| Change | - | -28.77% | 29.85% | -3.51% | -4.05% | -19.86% | 0% | 0% |
| P/E | 31.1x | 37.3x | 38.2x | 28.2x | 27.6x | 19.2x | 16.7x | 16.1x |
| PBR | 3.6x | 2.88x | - | - | 2.65x | 2.12x | - | - |
| PEG | - | -1x | 2.9x | 0.9x | -10.61x | 1.1x | 1.1x | 3.94x |
| Capitalization / Revenue | 7.32x | 5.26x | 5.77x | 5.68x | 5.14x | 3.9x | 3.79x | 3.62x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.9x | 3.79x | 3.62x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 10.2x | 9.76x | 8.95x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 18.4x | 16.4x | 13.7x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 15.5x | 11.5x | 10.3x |
| FCF Yield | 4.2% | 4.11% | 4.49% | 4.11% | 6.28% | 6.46% | 8.71% | 9.7% |
| Dividend per Share 2 | 0.91 | 1.02 | 1.11 | - | 1.32 | - | - | - |
| Rate of return | 0.98% | 1.51% | 1.42% | - | 1.82% | - | - | - |
| EPS 2 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 | 3.092 | 3.545 | 3.69 |
| Distribution rate | 30.6% | 56.4% | 54.1% | - | 50.4% | - | - | - |
| Net sales 1 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 | 1,426 | 1,467 | 1,535 |
| EBITDA 1 | 550.2 | 420.6 | 463.9 | 460.1 | 496.3 | 547.1 | 569.6 | 621.2 |
| EBIT 1 | 344.4 | 206.6 | 215.8 | 258.3 | 265 | 302.5 | 339.2 | 404.7 |
| Net income 1 | 310.2 | 184.1 | 200.7 | 261.8 | 255 | 255.7 | 292.3 | 349 |
| Net Debt | -1,272 | -817.6 | - | - | - | - | - | - |
| Reference price 2 | 92.47 | 67.46 | 78.36 | 75.84 | 72.39 | 59.36 | 59.36 | 59.36 |
| Nbr of stocks (in thousands) | 101,387 | 97,677 | 95,641 | 95,348 | 95,844 | 93,669 | - | - |
| Announcement Date | 11/16/21 | 11/17/22 | 11/16/23 | 11/19/24 | 11/18/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.19x | - | - | - | 5.56B | |
| 26.67x | 9.84x | 16.09x | 0.74% | 3,900B | |
| 122.01x | 53.97x | 87.88x | -.--% | 455B | |
| 21.45x | 6.07x | 10.63x | 1.4% | 432B | |
| 258.08x | 23.04x | 67.46x | -.--% | 333B | |
| 2726.7x | 45.73x | 149.55x | -.--% | 280B | |
| 26.19x | 5.25x | 16.57x | 1.45% | 239B | |
| 88.09x | 8.56x | 22.9x | -.--% | 141B | |
| 59.54x | 16.06x | 42.29x | -.--% | 135B | |
| 493.82x | 21.18x | 83.72x | -.--% | 99.25B | |
| Average | 384.17x | 21.08x | 55.23x | 0.4% | 601.93B | |
| Weighted average by Cap. | 181.65x | 15.43x | 32.07x | 0.64% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DLB Stock
- Valuation Dolby Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
